Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (40 ops.)
Latest filing published 28 Apr 2026 for Arcellx, Inc..
Filing timeline
BuySaleAndrew H. Galligan
Insider track record
Disclosed buys
0
Disclosed sells
40
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew H. Galligan: trading record in brief
Filings by Andrew H. Galligan span 4 companies, the busiest being Nevro Corp, Ooma Inc and Arcellx, Inc. Between 6 August 2013 and 28 April 2026, the trades on record add up to 95 filings.
The open-market record consists of 40 sales worth €15.0M, with no purchase. Besides market trades, the filings include 19 share grants and 35 option exercises.
On 28 April 2026 came the latest disclosure, a transaction in Arcellx, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew H. Galligan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,000 sharesCommon StockSEC:0001417976-26-000002:0
12,407 shares@ US$12.434639.8% of flowCommon StockSEC:0000950170-25-089617:0
11,556 shares0Common StockSEC:0000950170-25-083984:0
35,000 shares@ US$6.04100.0% of flowCommon StockSEC:0000950170-24-138441:0
19,762 shares0Common StockSEC:0000950170-24-070502:0
11,783 shares0Common StockSEC:0001209191-23-034665:0
11,355 shares0Common StockSEC:0001209191-22-034131:0
7,498 shares0Common StockSEC:0001209191-21-038371:0
8 of 8 declarations
